NASADIC

This brand name is authorized in Nigeria.

Active ingredients

The drug NASADIC contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100828	Injection	NASADIC DICLOFENAC SODIUM INJECTION BP 75MG/3ML INJ 75 mg/3 mL 3X2X5AMPS	57 NF-PP-382964 NASADIC DICLOFENAC SODIUM INJECTION BP 75MG/3ML DICLOFENAC SODIUM INJECTION BP 75MG/3ML. DICLOFENAC SODIUM INJECTION A4-100828 Drugs Imported Products 3X2X5AMPS Over The Counter (OTC) NASAJONES INDUSTRIES LTD, OFFICE COMPLEX MIDDLE ROAD BY ADO BAYERO SQUARE SABON GARI KANO KANO 0 nasajones2021@gmail.com Shandong Xier Kangtai Pharmaceutical Company Ltd, Private Economy Garden, Xinyan town Yanzhou Jining City Shandong China, China	30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB05	Diclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100828